Abstract Background: The impact of clonal haematopoiesis of indeterminate potential (CHIP), a novel cardiovascular risk factor, remains unclear in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), where cardiovascular disease (CVD) is the main cause of mortality. Methods: We analysed data from 140,086 UK Biobank participants with MASLD. CHIP was identified via whole-exome sequencing.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Heng
Contact Heng, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack